RAPT Therapeutics, Inc. Income (Loss) from Continuing Operations, Per Basic and Diluted Share
RAPT Therapeutics, Inc. reported Income (Loss) from Continuing Operations, Per Basic and Diluted Share of -$0.69 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-11.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare · last filed 2022-05-11
- RAPT Therapeutics, Inc. income (loss) from continuing operations, per basic and diluted share for the quarter ending 2022-03-31 was -$0.69.
- RAPT Therapeutics, Inc. income (loss) from continuing operations, per basic and diluted share for the quarter ending 2021-09-30 was -$0.63.
- RAPT Therapeutics, Inc. income (loss) from continuing operations, per basic and diluted share for the quarter ending 2021-06-30 was -$0.63.
- RAPT Therapeutics, Inc. income (loss) from continuing operations, per basic and diluted share for the quarter ending 2021-03-31 was -$0.66.
- RAPT Therapeutics, Inc. income (loss) from continuing operations, per basic and diluted share for fiscal 2021 was -$2.53.
- RAPT Therapeutics, Inc. income (loss) from continuing operations, per basic and diluted share for fiscal 2020 was -$2.19.
- RAPT Therapeutics, Inc. income (loss) from continuing operations, per basic and diluted share for fiscal 2019 was -$9.89, a 117.03% decline from fiscal 2018.
- RAPT Therapeutics, Inc. income (loss) from continuing operations, per basic and diluted share for fiscal 2018 was $58.09.
| Period end | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 12 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 12 month as first filed |
|---|---|---|---|---|---|
| 2022-03-31 | -$0.69 10-Q · filed 2022-05-11 | ||||
| 2021-12-31 | -$2.53 10-K · filed 2022-03-10 | ||||
| 2021-09-30 | -$0.63 10-Q · filed 2021-11-10 | -$1.92 10-Q · filed 2021-11-10 | |||
| 2021-06-30 | -$0.63 10-Q · filed 2021-08-11 | -$1.29 10-Q · filed 2021-08-11 | |||
| 2021-03-31 | -$0.66 10-Q · filed 2022-05-11 | ||||
| 2020-12-31 | -$2.19 10-K · filed 2022-03-10 | ||||
| 2020-09-30 | -$0.60 10-Q · filed 2021-11-10 | -$1.67 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | -$0.51 10-Q · filed 2021-08-11 | -$1.08 10-Q · filed 2021-08-11 | |||
| 2020-03-31 | -$0.56 10-Q · filed 2021-05-11 | ||||
| 2019-12-31 | -$9.89 10-K · filed 2021-03-11 | $9.89 10-K · filed 2020-03-30 | |||
| 2019-09-30 | -$12.41 10-Q · filed 2020-11-16 | -$40.15 10-Q · filed 2020-11-16 | |||
| 2019-06-30 | -$14.78 10-Q · filed 2020-08-13 | -$28.80 10-Q · filed 2020-08-13 | |||
| 2019-03-31 | -$13.28 10-Q · filed 2020-05-14 | ||||
| 2018-12-31 | $58.09 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | -$15.90 10-Q · filed 2019-12-11 | -$45.11 10-Q · filed 2019-12-11 |